The 2018 Alzheimer's Clinical Trials Report surveys the landscape of clinical trials for Alzheimer’s. The data in this report focus on 102 potential treatments for Alzheimer's disease in clinical development, highlighting an additional 15 drugs to address symptoms and 14 prevention drugs. We also analyze the current state of the field, and look ahead at the potential shifts and breakthroughs that can pave the way for a cure.
